Sandra A.W.M. Verkuijlen

1.3k total citations
27 papers, 803 citations indexed

About

Sandra A.W.M. Verkuijlen is a scholar working on Oncology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Sandra A.W.M. Verkuijlen has authored 27 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Infectious Diseases and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Sandra A.W.M. Verkuijlen's work include Viral-associated cancers and disorders (19 papers), Parvovirus B19 Infection Studies (11 papers) and Lymphoma Diagnosis and Treatment (8 papers). Sandra A.W.M. Verkuijlen is often cited by papers focused on Viral-associated cancers and disorders (19 papers), Parvovirus B19 Infection Studies (11 papers) and Lymphoma Diagnosis and Treatment (8 papers). Sandra A.W.M. Verkuijlen collaborates with scholars based in Netherlands, Indonesia and United States. Sandra A.W.M. Verkuijlen's co-authors include Jaap M. Middeldorp, Servi J.C. Stevens, I. Bing Tan, Astrid E. Greijer, Hedy Juwana, Monique Nijhuis, Rob Schuurman, Noortje van Maarseveen, Anton M. van Loon and Jajah Fachiroh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

Sandra A.W.M. Verkuijlen

27 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra A.W.M. Verkuijlen Netherlands 16 496 213 180 177 168 27 803
Héla Karray Tunisia 13 201 0.4× 143 0.7× 138 0.8× 77 0.4× 101 0.6× 48 520
Tadamasa Ooka France 19 568 1.1× 163 0.8× 320 1.8× 188 1.1× 149 0.9× 28 833
Monique G.C.T. van Oijen Netherlands 11 155 0.3× 143 0.7× 48 0.3× 42 0.2× 178 1.1× 11 543
Ryuichi Nakashima Japan 13 135 0.3× 74 0.3× 244 1.4× 73 0.4× 212 1.3× 18 606
Kevin J. Gilligan United States 10 488 1.0× 245 1.2× 202 1.1× 181 1.0× 236 1.4× 12 794
J. M. Seigneurin France 13 226 0.5× 141 0.7× 217 1.2× 132 0.7× 72 0.4× 26 608
Jennifer Berline United States 11 344 0.7× 116 0.5× 305 1.7× 107 0.6× 149 0.9× 13 716
Mitchell Hayes United States 16 614 1.2× 84 0.4× 242 1.3× 223 1.3× 242 1.4× 29 925
Thorsten Pfuhl Germany 10 343 0.7× 236 1.1× 151 0.8× 71 0.4× 469 2.8× 18 1.0k
Flávia Escremim de Paula Brazil 17 100 0.2× 234 1.1× 279 1.6× 31 0.2× 132 0.8× 37 677

Countries citing papers authored by Sandra A.W.M. Verkuijlen

Since Specialization
Citations

This map shows the geographic impact of Sandra A.W.M. Verkuijlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra A.W.M. Verkuijlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra A.W.M. Verkuijlen more than expected).

Fields of papers citing papers by Sandra A.W.M. Verkuijlen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra A.W.M. Verkuijlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra A.W.M. Verkuijlen. The network helps show where Sandra A.W.M. Verkuijlen may publish in the future.

Co-authorship network of co-authors of Sandra A.W.M. Verkuijlen

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra A.W.M. Verkuijlen. A scholar is included among the top collaborators of Sandra A.W.M. Verkuijlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra A.W.M. Verkuijlen. Sandra A.W.M. Verkuijlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bracht, Jillian Wilhelmina Paulina, Edwin van der Pol, Sandra A.W.M. Verkuijlen, et al.. (2024). Choice of size-exclusion chromatography column affects recovery, purity, and miRNA cargo analysis of extracellular vesicles from human plasma. PubMed. 5(3). 597–608. 7 indexed citations
2.
Drees, Esther E.E., Sandra A.W.M. Verkuijlen, Monique A.J. van Eijndhoven, et al.. (2024). Towards IVDR‐compliance by implementing quality control steps in a quantitative extracellular vesicle‐miRNA liquid biopsy assay for response monitoring in patients with classic Hodgkin lymphoma. SHILAP Revista de lepidopterología. 3(7). e164–e164. 3 indexed citations
3.
Moldován, Norbert, Sandra A.W.M. Verkuijlen, Ymke van der Pol, et al.. (2024). Comparison of cell-free and small extracellular-vesicle-associated DNA by sequencing plasma of lung cancer patients. iScience. 27(9). 110742–110742. 6 indexed citations
4.
Moldován, Norbert, Ymke van der Pol, Tom van den Ende, et al.. (2023). Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis. Cell Reports Medicine. 5(1). 101349–101349. 26 indexed citations
5.
Verkuijlen, Sandra A.W.M., et al.. (2023). EBV-IgA antibody responses in endemic and nonendemic populations with nasopharyngeal carcinoma: tumour marker prognostication study and a cross-sectional study. Annals of Medicine and Surgery. 85(9). 4394–4403. 1 indexed citations
6.
Pol, Ymke van der, Norbert Moldován, Sandra A.W.M. Verkuijlen, et al.. (2022). The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation. Clinical Chemistry. 68(6). 803–813. 29 indexed citations
7.
Novalić, Zlata, Sandra A.W.M. Verkuijlen, Jos Eersels, et al.. (2017). Cytolytic virus activation therapy and treatment monitoring for Epstein‐Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. Journal of Medical Virology. 89(12). 2207–2216. 12 indexed citations
8.
Greijer, A.E., et al.. (2016). Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells. Journal of Virological Methods. 241. 24–33. 13 indexed citations
9.
Wildeman, Maarten A., Zlata Novalić, Renske Fles, et al.. (2015). Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group. European Archives of Oto-Rhino-Laryngology. 273(6). 1557–1567. 16 indexed citations
10.
Novalić, Zlata, Maarten A. Wildeman, Alwin D. R. Huitema, et al.. (2015). Epstein–Barr virus-targeted therapy in nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology. 141(10). 1845–1857. 42 indexed citations
11.
Adham, Marlinda, Astrid E. Greijer, Sandra A.W.M. Verkuijlen, et al.. (2013). Epstein-Barr Virus DNA Load in Nasopharyngeal Brushings and Whole Blood in Nasopharyngeal Carcinoma Patients before and after Treatment. Clinical Cancer Research. 19(8). 2175–2186. 54 indexed citations
12.
Wildeman, Maarten A., Zlata Novalić, Sandra A.W.M. Verkuijlen, et al.. (2012). Cytolytic Virus Activation Therapy for Epstein-Barr Virus–Driven Tumors. Clinical Cancer Research. 18(18). 5061–5070. 73 indexed citations
13.
Greijer, A.E., Servi J.C. Stevens, Sandra A.W.M. Verkuijlen, et al.. (2012). Variable EBV DNA Load Distributions and Heterogeneous EBV mRNA Expression Patterns in the Circulation of Solid Organ versus Stem Cell Transplant Recipients. SHILAP Revista de lepidopterología. 2012. 1–10. 7 indexed citations
14.
Hutajulu, Susanna Hilda, Sandra A.W.M. Verkuijlen, Jajah Fachiroh, et al.. (2010). Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma. Infectious Agents and Cancer. 5(1). 20 indexed citations
15.
Stevens, Servi J.C., Paul H.M. Smits, Sandra A.W.M. Verkuijlen, et al.. (2007). Aberrant Epstein–Barr virus persistence in HIV carriers is characterized by anti-Epstein–Barr virus IgA and high cellular viral loads with restricted transcription. AIDS. 21(16). 2141–2149. 21 indexed citations
16.
Sanjosé, Sílvia de, Ramón Bosch, Tabitha Schouten, et al.. (2007). Epstein‐Barr virus infection and risk of lymphoma: Immunoblot analysis of antibody responses against EBV‐related proteins in a large series of lymphoma subjects and matched controls. International Journal of Cancer. 121(8). 1806–1812. 42 indexed citations
17.
Stevens, Servi J.C., Sandra A.W.M. Verkuijlen, Bambang Hariwiyanto, et al.. (2006). Noninvasive diagnosis of nasopharyngeal carcinoma: Nasopharyngeal brushings reveal high Epstein‐Barr virus DNA load and carcinoma‐specific viral BARF1 mRNA. International Journal of Cancer. 119(3). 608–614. 79 indexed citations
18.
Stevens, Servi J.C., C. Michel Zwaan, Sandra A.W.M. Verkuijlen, & Jaap M. Middeldorp. (2006). Epstein‐Barr virus (EBV) serology for predicting distant metastases in a white juvenile patient with nasopharyngeal carcinoma and no clinical response to EBV lytic induction therapy. Head & Neck. 28(11). 1040–1045. 12 indexed citations
19.
Stevens, Servi J.C., Sandra A.W.M. Verkuijlen, & Jaap M. Middeldorp. (2004). Quantitative Detection of Epstein-Barr Virus DNA in Clinical Specimens by Rapid Real-Time PCR Targeting a Highly Conserved Region of EBNA-1. Humana Press eBooks. 292. 15–26. 24 indexed citations
20.
Stevens, Servi J.C., Sandra A.W.M. Verkuijlen, Adriaan J. C. van den Brule, & Jaap M. Middeldorp. (2002). Comparison of Quantitative Competitive PCR with LightCycler-Based PCR for Measuring Epstein-Barr Virus DNA Load in Clinical Specimens. Journal of Clinical Microbiology. 40(11). 3986–3992. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026